Elínborg Ostermann
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
- Immunology and Allergy top 10%
Papers in
-
- Glycosylation and Glycoproteins Research 4
- RNA Interference and Gene Delivery 2
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Herbert R. Lamche (6 shared papers)Günther R. Adolf (4 shared papers)Dontscho Kerjaschki (1 shared paper)M. Kalat (1 shared paper)Erik Patzelt (3 shared papers)Guenther R. Adolf (2 shared papers)Pilar Garin‐Chesa (1 shared paper)Christina Puri (1 shared paper)
- Journals
- Blood (3 papers)Molecular Cancer Therapeutics (2 papers)Biochemical and Biophysical Research Communications (1 paper)Cancer Gene Therapy (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- AustriaGermanyNetherlands
In The Last Decade
Elínborg Ostermann
13 papers receiving 759 citations
Peers
Comparison fields: 5 of 60
- Oncology 282
- Immunology and Allergy 52
- Cell Biology 114
- Radiology, Nuclear Medicine and Imaging 132
- Cancer Research 86
Countries citing papers authored by Elínborg Ostermann
This map shows the geographic impact of Elínborg Ostermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elínborg Ostermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elínborg Ostermann more than expected).
Fields of papers citing papers by Elínborg Ostermann
This network shows the impact of papers produced by Elínborg Ostermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elínborg Ostermann. The network helps show where Elínborg Ostermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Elínborg Ostermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 198 | |
| 2 | 2001 | 79 | |
| 3 | 2011 | 78 | |
| 4 | 2013 | 74 | |
| 5 | 1996 | 69 | |
| 6 | 2002 | 68 | |
| 7 | 2002 | 65 | |
| 8 | 2002 | 47 | |
| 9 | 1995 | 44 | |
| 10 | 1995 | 44 | |
| 11 | 2012 | 4 | |
| 12 | 2011 | 2 | |
| 13 | 2010 | 1 |
About Elínborg Ostermann
Elínborg Ostermann is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Genetics and Endocrinology, Diabetes and Metabolism, having authored 13 papers that have together received 773 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (4 papers), Peptidase Inhibition and Analysis (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), RNA Interference and Gene Delivery (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Proteoglycans and glycosaminoglycans research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (282 citations), Immunology and Allergy (52 citations), Cell Biology (114 citations), Radiology, Nuclear Medicine and Imaging (132 citations) and Cancer Research (86 citations). Elínborg Ostermann has collaborated with scholars based in Austria, Germany and Netherlands. Frequent co-authors include Herbert R. Lamche, Günther R. Adolf, Dontscho Kerjaschki, M. Kalat, Erik Patzelt, Guenther R. Adolf, Pilar Garin‐Chesa, Christina Puri, Wolfgang J. Rettig and Karl‐Heinz Heider. Their work appears in journals such as Blood, Molecular Cancer Therapeutics, Biochemical and Biophysical Research Communications, Cancer Gene Therapy and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.